The final patient completing our pivotal F351 Phase 3 trial marks an important milestone for Gyre and our development pipeline. We are grateful to the patients, researchers, trial investigators, and ...

BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...

Milk thistle, known for its silymarin content, is celebrated for protecting the liver against damage, reducing inflammation, ...

Mice and ticks can endanger the health of you and your family, but you could inadvertently be inviting them into your yard ...

The study first used laboratory models of pulmonary TB to examine the changes happening within the liver during the early ...

Professor Ramou Njie made this disclosure recently during her presentation as part of activities marking liver cancer ...

Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

WEIGHT-LOSS jabs are the most talked about drugs of the moment. And with new studies popping up almost every week revealing ...

High levels of fat in your liver increases your risk of serious health problems, such as diabetes, high blood pressure and kidney disease ...

Cardiovascular disease (CVD) is the leading cause of death globally ... We’re working on new delivery systems for RNAi ...

Lipoproteins circulate throughout the body. You may have looked at your blood test results and wondered what they do. Find ...